ArticlePloS one2024

Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7).

PLOS ONE EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.